Washburn Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-625
| Closed | -$317K | – | 50 |
|
2023
Q3 | $317K | Hold |
625
| – | – | 0.27% | 38 |
|
2023
Q2 | $326K | Sell |
625
-325
| -34% | -$170K | 0.27% | 38 |
|
2023
Q1 | $548K | Buy |
950
+6
| +0.6% | +$3.46K | 0.47% | 34 |
|
2022
Q4 | $520K | Sell |
944
-10
| -1% | -$5.51K | 0.47% | 33 |
|
2022
Q3 | $484K | Sell |
954
-40
| -4% | -$20.3K | 0.46% | 31 |
|
2022
Q2 | $540K | Sell |
994
-5
| -0.5% | -$2.72K | 0.47% | 35 |
|
2022
Q1 | $590K | Sell |
999
-166
| -14% | -$98K | 0.39% | 38 |
|
2021
Q4 | $777K | Sell |
1,165
-20
| -2% | -$13.3K | 0.46% | 30 |
|
2021
Q3 | $677K | Sell |
1,185
-145
| -11% | -$82.8K | 0.44% | 36 |
|
2021
Q2 | $671K | Sell |
1,330
-10
| -0.7% | -$5.05K | 0.45% | 35 |
|
2021
Q1 | $612K | Buy |
1,340
+75
| +6% | +$34.3K | 0.42% | 39 |
|
2020
Q4 | $589K | Buy |
1,265
+90
| +8% | +$41.9K | 0.41% | 39 |
|
2020
Q3 | $519K | Buy |
+1,175
| New | +$519K | 0.41% | 35 |
|